{"disease":{"id":"igg4-related-disease","name":"igg4 related disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03267875","title":"A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT07068165","title":"A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":198,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT05662241","title":"A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":194,"lead_sponsor_name":"Zenas BioPharma (USA), LLC","has_results":false},{"nct_id":"NCT07535554","title":"The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT04540497","title":"A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":135,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04817553","title":"Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients","phase":"","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04125511","title":"Characterizing IgG4-RD With 68Ga-FAPI PET/CT","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT07536841","title":"Ambispective Validation of the Odesa Criteria 2026 (OC26): A Flexible Point-Based System for Diagnosis of Autoimmune Pancreatitis.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":82,"lead_sponsor_name":"Military Medical Clinical Center of the Southern Region, Ukraine","has_results":false},{"nct_id":"NCT02899039","title":"Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT06663618","title":"Short-term Glucocorticoid Combined with MMF for IgG4-RD","phase":"NA","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"Wen Zhang","has_results":false},{"nct_id":"NCT06794008","title":"BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07104058","title":"A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD","phase":"NA","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Luo Yaping","has_results":false},{"nct_id":"NCT07339540","title":"the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05625581","title":"Tofatib Treatment for IgG4-related Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT03466970","title":"Plasmablast Detection From IgG4-Related Disease Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT03690908","title":"Infraorbital Nerve Involvement on Magnetic Resonance Imaging in IgG4-related Ophthalmic Disease","phase":"","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Fondation Ophtalmologique Adolphe de Rothschild","has_results":false},{"nct_id":"NCT03368274","title":"To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Wen Zhang","has_results":false},{"nct_id":"NCT07061938","title":"Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Acepodia Biotech, Inc.","has_results":false},{"nct_id":"NCT06285279","title":"The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Nanjing University School of Medicine","has_results":false},{"nct_id":"NCT06655831","title":"Key Mechanisms of Abnormal T Cell Activation and Differentiation in IgG4-Related Ophthalmic Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT05746689","title":"Study of Sirolimus in IgG4-related Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Peking University International Hospital","has_results":false},{"nct_id":"NCT05728684","title":"Study to Evaluate the Efficacy and Safety of CM310 in Subjects With IgG4-related Disease","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT07298590","title":"An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-NK in the Treatment of Relapsed and Refractory IgG4-related Disease","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT06978647","title":"A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT04602598","title":"Zanubrutinib in Patients With IgG4-Related Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Matthew C. Baker","has_results":true},{"nct_id":"NCT03669861","title":"Safety and Efficacy of Abatacept in IgG4-Related Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT06361745","title":"Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"PersonGen BioTherapeutics (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT07148791","title":"Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT04918147","title":"Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT07025330","title":"A Study of Efgartigimod in Patients With IgG4-Related Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"Stanford University","has_results":false}],"total":30},"guidelines":[],"source":"Drug Landscape verified database"}